US Stock MarketDetailed Quotes
FLGT Fulgent Genetics
- 20.110
- +0.020+0.10%
Close Apr 18 16:00 ET
- 20.110
- 0.0000.00%
Post 16:20 ET
601.30MMarket Cap-3571P/E (TTM)
20.455High19.880Low219.60KVolume20.000Open20.090Pre Close4.44MTurnover1.10%Turnover RatioLossP/E (Static)29.90MShares44.09052wk High0.53P/B401.48MFloat Cap19.88052wk Low--Dividend TTM19.96MShs Float189.890Historical High--Div YieldTTM2.86%Amplitude2.725Historical Low20.204Avg Price1Lot Size
Fulgent Genetics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -53.27%289.21M | 4.14%70.51M | -19.85%84.69M | -45.87%67.85M | -79.34%66.17M | -37.64%618.97M | -73.10%67.7M | -53.63%105.66M | -18.41%125.34M | -10.90%320.27M |
| Operating revenue | -53.27%289.21M | 4.14%70.51M | -19.85%84.69M | -45.87%67.85M | -79.34%66.17M | -37.64%618.97M | -73.10%67.7M | -53.63%105.66M | -18.41%125.34M | -10.90%320.27M |
| Cost of revenue | -26.70%184.76M | -17.25%45.28M | -24.71%44.84M | -21.28%47.28M | -39.07%47.36M | 16.95%252.07M | -11.94%54.72M | 37.03%59.56M | 67.51%60.07M | 4.93%77.73M |
| Gross profit | -71.53%104.46M | 94.26%25.23M | -13.56%39.84M | -68.48%20.57M | -92.24%18.81M | -52.78%366.9M | -93.15%12.99M | -75.00%46.1M | -44.57%65.28M | -15.00%242.54M |
| Operating expense | -3.05%179.75M | 13.22%56.12M | -13.16%39.63M | -18.59%40.37M | 7.45%43.64M | 83.39%185.4M | 28.15%49.57M | 81.61%45.64M | 162.92%49.59M | 120.32%40.61M |
| Selling and administrative expenses | -13.02%130.47M | 8.09%42.21M | -23.44%27.66M | -30.14%28.72M | -5.43%31.89M | 99.53%149.99M | 28.86%39.05M | 97.29%36.13M | 203.41%41.11M | 159.15%33.72M |
| -Selling and marketing expense | 6.55%41.47M | 2.41%10.5M | 3.06%10.16M | -1.32%10.72M | 26.99%10.08M | 59.25%38.92M | 25.04%10.25M | 63.99%9.86M | 108.20%10.87M | 58.55%7.94M |
| -General and administrative expense | -19.87%89M | 10.12%31.71M | -33.38%17.5M | -40.50%17.99M | -15.41%21.8M | 118.94%111.07M | 30.27%28.79M | 113.56%26.27M | 263.07%30.24M | 222.11%25.78M |
| Research and development costs | 43.34%41.44M | 40.46%11.95M | 33.40%10.01M | 40.36%9.69M | 63.33%9.78M | 19.37%28.91M | 14.00%8.51M | 24.68%7.51M | 29.99%6.91M | 10.46%5.99M |
| Depreciation amortization depletion | 20.75%7.85M | -2.59%1.96M | -2.44%1.96M | 24.57%1.96M | 117.22%1.97M | 280.39%6.5M | 120.64%2.01M | 151.69%2.01M | --1.58M | --906K |
| -Depreciation and amortization | 20.75%7.85M | -2.59%1.96M | -2.44%1.96M | 24.57%1.96M | 117.22%1.97M | 280.39%6.5M | 120.64%2.01M | 151.69%2.01M | --1.58M | --906K |
| Operating profit | -141.48%-75.3M | 15.56%-30.89M | -53.17%214K | -226.18%-19.8M | -112.29%-24.82M | -73.15%181.5M | -124.25%-36.58M | -99.71%457K | -84.14%15.69M | -24.35%201.93M |
| Net non-operating interest income expense | 290.03%21.44M | 91.75%5.93M | 373.02%6.65M | 432.15%5.1M | 8,288.89%3.78M | 308.17%5.5M | 8,928.57%3.09M | 183.27%1.41M | 58.61%958K | -84.04%45K |
| Non-operating interest income | 290.03%21.44M | 91.75%5.93M | 373.02%6.65M | 432.15%5.1M | 8,288.89%3.78M | 308.17%5.5M | 8,928.57%3.09M | 183.27%1.41M | 58.61%958K | -84.04%45K |
| Other net income (expense) | -3,941.48%-120.23M | -2.98M | 26K | -105K | -2.9M | |||||
| Special income (charges) | -3,941.48%-120.23M | -462,538.46%-120.23M | --0 | --0 | ---- | ---2.98M | --26K | ---105K | ---2.9M | ---- |
| -Less：Restructuring and merger&acquisition | --0 | --0 | --0 | --0 | ---- | --2.98M | ---26K | --105K | --2.9M | ---- |
| -Less:Impairment of capital assets | --120.23M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Income before tax | -194.60%-174.09M | -333.91%-145.2M | 290.44%6.86M | -206.89%-14.7M | -110.42%-21.05M | -72.83%184.03M | -122.19%-33.46M | -98.90%1.76M | -86.18%13.75M | -24.41%201.98M |
| Income tax | -97.26%1.15M | -15.73%-10.86M | 4,809.66%20.33M | -217.23%-3.11M | -110.74%-5.2M | -75.91%42.1M | -119.91%-9.39M | -98.90%414K | -88.75%2.65M | -27.20%48.42M |
| Earnings from equity interest net of tax | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net income | -223.47%-175.24M | -457.96%-134.33M | -1,102.68%-13.47M | -204.42%-11.59M | -110.32%-15.85M | -71.97%141.92M | -123.22%-24.08M | -98.90%1.34M | -86.06%11.1M | -23.49%153.56M |
| Net income continuous Operations | -223.47%-175.24M | -457.96%-134.33M | -1,102.68%-13.47M | -204.42%-11.59M | -110.32%-15.85M | -71.97%141.92M | -123.22%-24.08M | -98.90%1.34M | -86.06%11.1M | -23.49%153.56M |
| Minority interest income | -400.95%-7.41M | -2,434.84%-6.19M | 4.52%-359K | 17.58%-361K | -20.62%-509K | -31.56%-1.48M | 63.14%-244K | -26.17%-376K | -165.45%-438K | -422K |
| Net income attributable to the parent company | -217.03%-167.83M | -437.72%-128.15M | -862.48%-13.11M | -197.33%-11.23M | -109.96%-15.34M | -71.74%143.4M | -122.84%-23.83M | -98.60%1.72M | -85.54%11.54M | -23.28%153.98M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -217.03%-167.83M | -437.72%-128.15M | -862.48%-13.11M | -197.33%-11.23M | -109.96%-15.34M | -71.74%143.4M | -122.84%-23.83M | -98.60%1.72M | -85.54%11.54M | -23.28%153.98M |
| Basic earnings per share | -218.28%-5.63 | -437.50%-4.3 | -833.33%-0.44 | -200.00%-0.38 | -110.22%-0.52 | -72.41%4.76 | -122.99%-0.8 | -98.55%0.06 | -86.13%0.38 | -26.87%5.09 |
| Diluted earnings per share | -221.60%-5.63 | -437.50%-4.3 | -833.33%-0.44 | -202.70%-0.38 | -110.55%-0.52 | -71.73%4.63 | -123.95%-0.8 | -98.47%0.06 | -85.71%0.37 | -24.39%4.93 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg